期刊文献+

Cyr61基因与慢性粒细胞白血病的相关性研究 被引量:3

Correlation between Cyr61 and chronic myelogenous leukemia
原文传递
导出
摘要 目的探讨慢性粒细胞白血病(CML)患者骨髓单个核细胞(BMMNC)中富半胱氨酸61基因(Cyr61)的表达水平及其临床意义。方法应用半定量RT-PCR和免疫组化技术分别检测38例CML患者和10例正常对照者(正常对照组)骨髓单个核细胞中Cyr61mRNA和蛋白水平的表达情况,CML患者中慢性期20例(慢性期组),加速期11例(加速期组),急变期7例(急变期组)。结果38例CML患者中,慢性期组、加速期组、急变期组Cyr61mRNA的表达明显高于正常对照组(P<0.05)。Cyr61基因在加速期及急变期的表达高于慢性期(P<0.05),Cyr61基因在加速期和急变期的表达虽升高,但两者差异无统计学意义(P>0.05)。Cyr61蛋白在CML中的表达明显高于正常对照组,CML加速期和急变期中Cyr61蛋白的表达高于慢性期(P均<0.05)。结论Cyr61基因参与了CML的发生、发展过程,且与CML的急变有关,可作为预示CML急变的实验依据。 Objective To investigate the chnical significance of cysteine rich 61(Cyr61)in the bone man'ow (BM) of chronic myelogenous leukemia(CML) patients. Methods Expressions of Cyt61 mRNA and Cytrl protein were detected in bone marrow mononuclear cells(BMMNC) from 38 patients with CML (20 chronic phase, 11 accelerated phase and 7 blast crisis) and 10 norreal controls by the reverse transcriptase -polymerase chain reaction (RT-PCR) method and immtmohistochemistry, respectively. Results Expression of Cyr61mRNA in a chronic phase, accelerated phase and blast crisis was significantly higher in CML patients than in normal controls( P 〈 0.05). Expression of the Cyr61 gene was higher in an accelerated phase and blast crisis than in the chronic phase( P 〈 0. 05), but showed no significance ( P 〉 0.05). Expression of Cyr61 protein was higher in CML patients than in normal controls(P 〈 0. 05). Expression of Cyr61 protein was higher in the accelerated phase and blast crisis than in the chronic phase( P 〈 0.05). Conclusion Over-expression of the Cyrrl gene which plays an important role in the acute transformation of chronic myelogenous leukemia may relate to the progression and genesis of CML and provides an experimental basis for early diagnosis of CML blastic crisis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第10期94-97,共4页 Journal of Shandong University:Health Sciences
关键词 白血病 慢性 粒细胞性 富半胱氨酸61 逆转录聚合酶链反应 Leukemia chronic myelogenous Cysteine rich 61 Reverse transcriptase-polymerase chain reaction
  • 相关文献

参考文献11

  • 1kireeva M L, Mo F E, Yang J P, et al. Cyr61, a product Of a growth factor-inducible mmediate-early gene, promotes cell proliferation migration and adhesion[J]. Mol Cell Bio, 1996, 16(4) : 1326-1334.
  • 2Bable A M, Kirceva M L, Kolesnikova T V, et al. Cyr61 a product of a growth fatter-inducible immediate early gene. promotes angiogenesis and tumor growth [ J ]. Proc Natl Acad Sci USA, 1998, 95 ( 11 ) : 6355-6360.
  • 3唐琼兰,刘卫平,张文燕,杨帆,何妙侠,夏庆杰,李甘地.CYR61和血管内皮生长因子在结外鼻型NK/T细胞淋巴瘤中的表达及其意义[J].中华血液学杂志,2006,27(10):661-665. 被引量:24
  • 4Holloway S E, Beck A W, Girard L, et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer[J]. J Am Coll Surg, 2005, 200(3) : 371-377.
  • 5Gery S, Xie D, Yin D, et al. Ovarian carcinomas CCN genes are aberrantly expressed and CCNI promotes proliferation of these cells[J]. Clin Cancer Res, 2005, 11(20):7243-7254.
  • 6Jay P, Berge-Lefranc J L, Marsollier C, et al. The human growth factor-inducible immediate early gene. CYR61, maps to chromosome 1p[J]. Oncogene, 1997, 14(14):1753-1757.
  • 7Jiang W G, Watkins G, Fodstad O, et al. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer [ J ]. Endocr Relat Cancer, 2004, 11(4) : 781-791.
  • 8Menendez J A, Vellon L, Mehmi I, et al. A novel Cyr61-triggered' CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and Chemosensitivity through activation of ERKI/ ERK2 MAPK signahng pathway[J]. Oncogene, 2005, 24(5) : 761-779.
  • 9Leu S J, Lain S C, Lau L F. Pro-angiogenic activities of Cyr61 (CCN1) mediated through integrins alphavbeta3 and alpha6betal in human umbilical vein endothelial cels[J]. J Biol Chem, 2002, 277(48) :46248-46255.
  • 10Tong X, O'Klly J, Ie D, et al. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc- p55 pathway[J]. Oncogene, 2004, 23(28):4847-4855.

二级参考文献1

共引文献23

同被引文献29

  • 1贺其图,赵晓华,贾国荣,马宏杰,李静,李喆,刘学文,云雁.白血病患者骨髓血管新生与Bcl-2蛋白关系的研究[J].实用癌症杂志,2006,21(4):376-378. 被引量:9
  • 2Brigstock DR. The connective tissue growth factor/cysteine- rich 61/nephroblastoma overexpressed (CCN) family[J]. En- docr Rev,1999,20(2) :189-206.
  • 3Kireeva ML, MO FE, Yang GP, et al. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion [J]. Mol Cell Biol, 1996,16(4) : 1326-34.
  • 4Hashimoto G, Inoki I, Fujii Y, et al. Matrix metalloprotein- ases cleave connective tissue growth factor and reactivate an- giogenic activity of vascular endothelial growth factor 165[J]. Biol Chem,2002,277(39) :36288-95.
  • 5Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins[J]. Int J Biochem Cell Biol, 2009,41 (4) :771-83.
  • 6Menfindez JA, Mehmi I, Griggs DW, et al. The angiogenic factor CYR61 in breast cancer: molecular pathology and ther- apeutic perspectives[J]. Endocr Relat Cancer, 2003,10 (2) : 141-52.
  • 7Aikawa T, Gunn J, Spong SM, et al. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer[J]. Mol Cancer Ther, 2006,5(5) : 1108-16.
  • 8Kang Y, Siegel PM, Shu W, et al. A multigenic program me- diating breast cancer metastasis to bone [J]. Cancer Cell, 2003,3(6) :537-49.
  • 9Shimo T, Kubota S, Yoshioka N, et al. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer[J]. Bone Miner Res, 2006,21(7) : 1045-59.
  • 10Tong X, Xie D, O'Kelly J,et al. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer [J]. Biol Chem,2001,276(50) :47709-14.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部